Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type

被引:54
作者
Ueyama, Hiroya [1 ]
Yao, Takashi [2 ]
Akazawa, Yoichi [1 ]
Hayashi, Takuo [3 ]
Kurahara, Koichi [4 ]
Oshiro, Yumi [5 ]
Yamada, Masaoshi [6 ]
Oda, Ichiro [6 ]
Fujioka, Shin [7 ]
Kusumoto, Chiaki [8 ]
Fukuda, Masayoshi [9 ]
Uchita, Kunihisa [10 ]
Kadota, Tomohiro [11 ]
Oono, Yasuhiro [11 ]
Okamoto, Kazuhisa [12 ]
Murakami, Kazunri [12 ]
Matsuo, Yasumasa [13 ]
Kato, Motohiko [14 ,15 ]
Maehata, Tadateru [15 ]
Yahagi, Naohisa [15 ]
Yasuhara, Yumiko [16 ]
Yada, Tomoyuki [17 ]
Uraushihara, Koji [18 ]
Yamane, Tetumi [19 ]
Matsuo, Taiji [20 ]
Ito, Masanori [21 ]
Maruyama, Yasuhiko [22 ]
Osako, Ayumi [23 ]
Ono, Shoko [24 ]
Kato, Mototsugu [25 ]
Yagi, Kazuyoshi [26 ]
Hashimoto, Takashi [27 ]
Tomita, Natsumi [27 ]
Tsuyama, Sho [3 ]
Saito, Tsuyoshi [3 ]
Matsumoto, Kohii [1 ]
Matsumoto, Kenshi [1 ]
Watanabe, Sumio [1 ]
Uemura, Naomi [17 ]
Chiba, Tsutomu [28 ,29 ]
Nagahara, Akihiito [1 ]
机构
[1] Juntendo Univ, Dept Gastroenterol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[2] Juntendo Univ, Dept Human Pathol, Grad Sch Med, Tokyo, Japan
[3] Juntendo Univ, Dept Human Pathol, Sch Med, Tokyo, Japan
[4] Matsuyama Red Cross Hosp, Dept Gastroenterol, Matsuyama, Ehime, Japan
[5] Matsuyama Red Cross Hosp, Dept Pathol, Matsuyama, Ehime, Japan
[6] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan
[7] Fukuoka Red Cross Hosp, Div Gastroenterol, Fukuoka, Japan
[8] Nippon Kokan Fukuyama Hosp, Dept Gastroenterol, Hiroshima, Japan
[9] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan
[10] Kochi Red Cross Hosp, Dept Gastroenterol, Kochi, Japan
[11] Natl Canc Ctr Hosp East, Dept Gastroenterol & Endoscopy, Chiba, Japan
[12] Oita Univ, Fac Med, Dept Gastroenterol, Oita, Japan
[13] St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan
[14] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
[15] Keio Univ, Canc Ctr, Div Res & Dev Minimally Invas Treatment, Sch Med, Tokyo, Japan
[16] Kyoto Katsura Hosp, Dept Diagnost Pathol, Kyoto, Japan
[17] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan
[18] Showa Gen Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[19] Tottori Red Cross Hosp, Dept Diagnost Pathol, Tottori, Japan
[20] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan
[21] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan
[22] Fujieda Municipal Gen Hosp, Dept Gastroenterol, Shizuoka, Japan
[23] Tottori Seikyo Hosp, Dept Gastroenterol, Tottori, Japan
[24] Hokkaido Univ Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[25] Hakodate Natl Hosp, Dept Gastroenterol, Natl Hosp Org, Hakodate, Hokkaido, Japan
[26] Niigata Univ Med & Dent Hosp, Uonuma Inst Community Med, Dept Gastroenterol & Hepatol, Niigata, Japan
[27] Juntendo Univ, Dept Esophageal & Gastroenterol Surg, Sch Med, Tokyo, Japan
[28] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan
[29] Kansai Elect Power Hosp, Osaka, Japan
关键词
Gastric adenocarcinoma of fundic-gland type; Gastric adenocarcinoma of fundic-gland mucosa type; Gastric epithelial neoplasm of fundic-gland mucosa lineage; Oxyntic gland adenoma; CATENIN SIGNALING PATHWAY; WELL-DIFFERENTIATED ADENOCARCINOMA; STOMACH; MUTATION; ADENOMA; GNAS;
D O I
10.1007/s00535-021-01813-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Gastric adenocarcinoma of fundic-gland type (GA-FG) is a rare variant of gastric neoplasia. However, the etiology, classification, and clinicopathological features of gastric epithelial neoplasm of fundic-gland mucosa lineage (GEN-FGML; generic term of GA-FG related neoplasm) are not fully elucidated. We performed a large, multicenter, retrospective study to establish a new classification and clarify the clinicopathological features of GEN-FGML. Methods One hundred GEN-FGML lesions in 94 patients were collected from 35 institutions between 2008 and 2019. We designed a new histopathological classification of GEN-FGML using immunohistochemical analysis and analyzed via clinicopathological, immunohistochemical, and genetic evaluation. Results GEN-FGML was classified into 3 major types; oxyntic gland adenoma (OGA), GA-FG, and gastric adenocarcinoma of fundic-gland mucosa type (GA-FGM). In addition, GA-FGM was classified into 3 subtypes; Type 1 (organized with exposure type), Type 2 (disorganized with exposure type), and Type 3 (disorganized with non-exposure type). OGA and GA-FG demonstrated low-grade epithelial neoplasm, and GA-FGM should be categorized as an aggressive variant of GEN-FGML that demonstrated high-grade epithelial neoplasm (Type 2 > 1, 3). The frequent presence of GNAS mutation was a characteristic genetic feature of GEN-FGML (7/34, 20.6%; OGA 1/3, 33.3%; GA-FG 3/24, 12.5%; GA-FGM 3/7, 42.9%) in mutation analysis using next-generation sequencing. Conclusions We have established a new histopathological classification of GEN-FGML and propose a new lineage of gastric epithelial neoplasm that harbors recurrent GNAS mutation. This classification will be useful to estimate the malignant potential of GEN-FGML and establish an appropriate standard therapeutic approach.
引用
收藏
页码:814 / 828
页数:15
相关论文
共 41 条
[41]   Extremely well-differentiated adenocarcinoma of the stomach: Clinicopathological and immunohistochemical features [J].
Yao, Takashi ;
Utsunomiya, Takashi ;
Oya, Masafumi ;
Nishiyama, Kenichi ;
Tsuneyoshi, Masazumi .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (16) :2510-2516